Related Experiment Videos

[Interferons and nucleoside analogs. New perspectives in therapy of chronic viral hepatitis]

H Hinrichsen¹, W E Schmidt

¹I. Medizinische Klinik, Christian-Albrechts-Universität, Kiel.

|April 8, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effects of the macroalga Laurencia snackeyi on enteric methane emission and lactational performance in dairy cows.

Journal of dairy science·2026

SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in Germany.

Primary care diabetes·2026

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

[Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports].

Der Internist·2017

Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry.

Journal of viral hepatitis·2017

[Recurrent hypoglycemia due to an occult insulinoma].

Der Internist·2016

See all related articles